Ruth Bader Ginsburg’s Collar: A Pointed History

ImageRuth Bader Ginsburg on Supreme Court class photo day in 2010.Credit…Doug Mills/The New York Times In 2014, the Supreme Court Justice Ruth Bader Ginsburg, the pioneering legal mind and advocate for equal treatment of the sexes who died on Friday, did something that probably none of her male colleagues were ever asked to do: she…

Details

Study shows the major impact of diabetes on the risk of falls

New research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated…

Details

First new drug in years reduces recurrence in high risk HR+ early breast cancer

Lugano, Switzerland, 20 September 2020 — Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020. (1) «This is the first time in more…

Details

No benefit for post-operative radiotherapy in non-small-cell lung cancer

Lugano, Switzerland, 20 September 2020 — Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020. These results give the oncology community a long-awaited answer. (1) PORT in completely…

Details

ESMO 2020: Breast cancer drug set to transform prostate cancer treatment

A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice. Final results from the trial showed that olaparib — a pioneering type of drug called…

Details

In ‘Power Grab,’ Health Secretary Azar Asserts Authority Over F.D.A.

In a stunning declaration of authority, Alex M. Azar II, the secretary of health and human services, this week barred the nation’s health agencies, including the Food and Drug Administration, from signing any new rules regarding the nation’s foods, medicines, medical devices and other products, including vaccines. Going forward, Mr. Azar wrote in a Sept.…

Details